Analyst Ratings for Supernus Pharmaceuticals (SUPN)
SUPN Rating Summary
SUPN Price Target Summary
- Highest: $43.00 (Piper Sandler)
- Lowest: $38.00 (Stifel)
- Average: $40.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$40.33 (+33.3%)
* Over Last 12-Mos
Rating Score: 7.3 / 10 Percentile Rank: 78%
Rating Score: 7.3 / 10 Percentile Rank: 78%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
12/1/2021 | Jefferies » Updated 4/8/2024 |
Irene Buhalo | New Coverage | Buy (N/A) |
40.00 (N/A) |
30.41 (30.26) |
-0.49% | Details |
6/16/2020 | Piper Sandler » Updated 11/9/2023 |
David Amsellem | Upgrade | Overweight (Neutral) |
43.00 (42.00) |
22.83 (30.26) |
32.54% | Details |